Phase III Measure Up 2 study of Rinvoq in atopic dermatitis meets primary and secondary endpoints July 22, 2020 No Comments
Lilly reports OASIS-2 data with mirikizumab in moderate to severe plaque psoriasis July 17, 2020 No Comments
Arcutis begins phase IIb portion of phase I/IIb study of ARQ-252 for chronic hand eczema July 14, 2020 No Comments
Kymera and Sanofi partner on IRAK4 protein degraders in inflammation and immunology July 10, 2020 No Comments
Cabaletta opens enrollment in phase I study of DSG3-CAART in mucosal-dominant pemphigus vulgaris July 7, 2020 No Comments
New phase II trial evaluates CBP-201 for moderate to severe atopic dermatitis July 6, 2020 No Comments